These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23009245)

  • 1. Orally active metabotropic glutamate subtype 2 receptor positive allosteric modulators: structure-activity relationships and assessment in a rat model of nicotine dependence.
    Sidique S; Dhanya RP; Sheffler DJ; Nickols HH; Yang L; Dahl R; Mangravita-Novo A; Smith LH; D'Souza MS; Semenova S; Conn PJ; Markou A; Cosford ND
    J Med Chem; 2012 Nov; 55(22):9434-45. PubMed ID: 23009245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of systemically active metabotropic glutamate subtype-2 and -3 (mGlu2/3) receptor positive allosteric modulators (PAMs): pharmacological characterization and assessment in a rat model of cocaine dependence.
    Dhanya RP; Sheffler DJ; Dahl R; Davis M; Lee PS; Yang L; Nickols HH; Cho HP; Smith LH; D'Souza MS; Conn PJ; Der-Avakian A; Markou A; Cosford ND
    J Med Chem; 2014 May; 57(10):4154-72. PubMed ID: 24735492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats.
    Li X; D'Souza MS; Niño AM; Doherty J; Cross A; Markou A
    Psychopharmacology (Berl); 2016 May; 233(10):1801-14. PubMed ID: 26873083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function.
    Noetzel MJ; Rook JM; Vinson PN; Cho HP; Days E; Zhou Y; Rodriguez AL; Lavreysen H; Stauffer SR; Niswender CM; Xiang Z; Daniels JS; Jones CK; Lindsley CW; Weaver CD; Conn PJ
    Mol Pharmacol; 2012 Feb; 81(2):120-33. PubMed ID: 22021324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor.
    Trabanco AA; Tresadern G; Macdonald GJ; Vega JA; de Lucas AI; Matesanz E; García A; Linares ML; Alonso de Diego SA; Alonso JM; Oehlrich D; Ahnaou A; Drinkenburg W; Mackie C; Andrés JI; Lavreysen H; Cid JM
    J Med Chem; 2012 Mar; 55(6):2688-701. PubMed ID: 22352782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys.
    Justinova Z; Panlilio LV; Secci ME; Redhi GH; Schindler CW; Cross AJ; Mrzljak L; Medd A; Shaham Y; Goldberg SR
    Biol Psychiatry; 2015 Oct; 78(7):452-62. PubMed ID: 25802079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships.
    Gregory KJ; Noetzel MJ; Rook JM; Vinson PN; Stauffer SR; Rodriguez AL; Emmitte KA; Zhou Y; Chun AC; Felts AS; Chauder BA; Lindsley CW; Niswender CM; Conn PJ
    Mol Pharmacol; 2012 Nov; 82(5):860-75. PubMed ID: 22863693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in rats.
    Dhanya RP; Sidique S; Sheffler DJ; Nickols HH; Herath A; Yang L; Dahl R; Ardecky R; Semenova S; Markou A; Conn PJ; Cosford ND
    J Med Chem; 2011 Jan; 54(1):342-53. PubMed ID: 21155570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
    Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
    Neuropharmacology; 2017 Mar; 115():115-127. PubMed ID: 28216000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu3) NAM probe (ML289) derived from a closely related mGlu5 PAM.
    Sheffler DJ; Wenthur CJ; Bruner JA; Carrington SJ; Vinson PN; Gogi KK; Blobaum AL; Morrison RD; Vamos M; Cosford ND; Stauffer SR; Daniels JS; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3921-5. PubMed ID: 22607673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro characterisation of the novel positive allosteric modulators of the mGlu₅ receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant responding in the rat.
    Gilmour G; Broad LM; Wafford KA; Britton T; Colvin EM; Fivush A; Gastambide F; Getman B; Heinz BA; McCarthy AP; Prieto L; Shanks E; Smith JW; Taboada L; Edgar DM; Tricklebank MD
    Neuropharmacology; 2013 Jan; 64():224-39. PubMed ID: 22884720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.
    Jones CK; Bubser M; Thompson AD; Dickerson JW; Turle-Lorenzo N; Amalric M; Blobaum AL; Bridges TM; Morrison RD; Jadhav S; Engers DW; Italiano K; Bode J; Daniels JS; Lindsley CW; Hopkins CR; Conn PJ; Niswender CM
    J Pharmacol Exp Ther; 2012 Feb; 340(2):404-21. PubMed ID: 22088953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and SAR of novel series of imidazopyrimidinones and dihydroimidazopyrimidinones as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5).
    Martín-Martín ML; Bartolomé-Nebreda JM; Conde-Ceide S; Alonso de Diego SA; López S; Martínez-Viturro CM; Tong HM; Lavreysen H; Macdonald GJ; Steckler T; Mackie C; Bridges TM; Daniels JS; Niswender CM; Noetzel MJ; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1310-7. PubMed ID: 25683622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lead optimization of the VU0486321 series of mGlu1 PAMs. Part 1: SAR of modifications to the central aryl core.
    Garcia-Barrantes PM; Cho HP; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5107-10. PubMed ID: 26476971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
    Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
    Neuropharmacology; 2016 Dec; 111():253-265. PubMed ID: 27590915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of dual positive allosteric modulators (PAMs) of the metabotropic glutamate 2 receptor and CysLT1 antagonists for treating migraine headache.
    Blanco MJ; Benesh DR; Knobelsdorf JA; Khilevich A; Cortez GS; Mokube F; Aicher TD; Groendyke TM; Marmsater FP; Tang TP; Johnson KW; Clemens-Smith A; Muhlhauser MA; Swanson S; Catlow J; Emkey R; Johnson MP; Schkeryantz JM
    Bioorg Med Chem Lett; 2017 Jan; 27(2):323-328. PubMed ID: 27908761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery, synthesis, and structure-activity relationship development of a series of N-4-(2,5-dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): characterization of a novel positive allosteric modulator of the metabotropic glutamate receptor 4 (mGlu(4)) with oral efficacy in an antiparkinsonian animal model.
    Jones CK; Engers DW; Thompson AD; Field JR; Blobaum AL; Lindsley SR; Zhou Y; Gogliotti RD; Jadhav S; Zamorano R; Bogenpohl J; Smith Y; Morrison R; Daniels JS; Weaver CD; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    J Med Chem; 2011 Nov; 54(21):7639-47. PubMed ID: 21966889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydronaphthyridine and dihydronaphthyridinone ethers as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu₅).
    Turlington M; Malosh C; Jacobs J; Manka JT; Noetzel MJ; Vinson PN; Jadhav S; Herman EJ; Lavreysen H; Mackie C; Bartolomé-Nebreda JM; Conde-Ceide S; Martín-Martín ML; Tong HM; López S; MacDonald GJ; Steckler T; Daniels JS; Weaver CD; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    J Med Chem; 2014 Jul; 57(13):5620-37. PubMed ID: 24914612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery, synthesis, and structure-activity relationship development of a series of N-(4-acetamido)phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu(4)) with CNS exposure in rats.
    Engers DW; Field JR; Le U; Zhou Y; Bolinger JD; Zamorano R; Blobaum AL; Jones CK; Jadhav S; Weaver CD; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    J Med Chem; 2011 Feb; 54(4):1106-10. PubMed ID: 21247167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro binding of a radio-labeled positive allosteric modulator for metabotropic glutamate receptor subtype 5.
    Zysk JR; Spear N; Fieles W; Stein MM; Sygowski LS; King MM; Hoesch V; Hastings R; Brockel B; Do M; Ström P; Gadient R; Chhajlani V; Elmore CS; Maier DL
    Synapse; 2013 Mar; 67(3):135-44. PubMed ID: 23150216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.